The Myth Of Lobbyistsdescriptionpart Ilobbyists Have Been
Part Of The
Analyze two examples of how lobbyists influence healthcare legislation, including their specific interests, ethical issues, and moral disputes. Conclude with your opinion on whether lobbyists have a positive or negative impact on healthcare legislation in the United States, supporting your position with evidence from at least five credible sources, including three from the Rasmussen College Online Library. Include in-text citations and an APA-formatted references page.
Create a detailed meeting agenda for a discussion with your supervisor and department heads about your findings. Focus primarily on the effects of lobbyists' actions on healthcare legislation, explaining each example thoroughly. Use audience-specific language, professional formatting, and ensure the agenda reflects a clear, businesslike presentation.
Paper For Above instruction
The influence of lobbyists on healthcare legislation in the United States has been a subject of ongoing debate. Lobbyists, representing various interest groups, play a significant role in shaping policies that affect public health, access to care, and the cost of healthcare services. This paper examines two specific examples of how lobbyists have impacted healthcare legislation, explores the ethical and moral issues involved, and evaluates whether their actions have ultimately been beneficial or detrimental to the healthcare system.
Example 1: The Pharmaceutical Industry and Drug Pricing Legislation
The pharmaceutical industry has historically employed lobbyists to influence legislation related to drug pricing, patent laws, and approval processes. One notable example is the industry's efforts during the debate over the Affordable Care Act (ACA). Lobbyists sought to protect patent protections for branded drugs, aiming to extend monopolies and prevent generic competition. This interest was primarily driven by the desire to maximize profits, often at the expense of affordability for consumers. Ethical concerns arose as these lobbying activities contributed to higher drug prices, limiting access for underinsured and uninsured populations. Critics argued that such lobbying practices prioritized corporate profits over patients' health needs, raising questions about moral obligations to serve public welfare.
Example 2: The American Medical Association (AMA) and Scope of Practice Laws
The AMA has historically lobbied to influence scope of practice laws governing advanced practice
registered nurses (APRNs) and physician assistants. The organization's interest lies in maintaining physician-led healthcare models, which it argues ensures high-quality patient care. However, opponents contend that this lobbying can create barriers for APRNs and other healthcare providers seeking to expand their roles, thereby limiting access to primary care, especially in underserved areas. Ethical issues include the balance between ensuring quality care and improving access; morally, restrictions may conflict with principles of healthcare equity and justice. The AMA's efforts highlight tensions between protecting professional standards and addressing healthcare disparities.
Analysis and Ethical Considerations
In both examples, lobbying efforts reflect powerful interest groups seeking to influence policies that benefit their members or industries. While these groups often argue that their advocacy improves healthcare quality or protects professional standards, ethical concerns revolve around transparency, undue influence, and the potential for conflicts of interest. For instance, industry-funded lobbying can compromise policymaking by prioritizing financial interests over public health needs.
Impact on Healthcare Legislation: Positive or Negative?
Assessing whether lobbyists' actions are beneficial or harmful reveals a complex picture. On one hand, lobbying can lead to more informed policies, as interest groups provide expert knowledge and data. On the other hand, excessive influence by well-funded interest groups can distort legislation, favoring corporate profits over patient outcomes or equitable access. Evidence suggests that some lobbying efforts have resulted in legislation that perpetuates high costs and constraints on healthcare innovation (Shulman & Ross, 2019). Hence, while lobbying can serve as a mechanism for advocacy, its negative impacts often overshadow potential benefits, especially when transparency is lacking.
Conclusion
In conclusion, lobbyists significantly influence healthcare legislation in the United States, often shaping policies in ways that favor industry interests over public health needs. Critics argue that such influence can lead to negative consequences, including higher costs, restricted access, and ethical dilemmas regarding transparency and fairness. While lobbying can provide valuable expertise, unchecked influence fosters an environment where corporate interests may undermine the broader goal of equitable, accessible healthcare. Therefore, the actions of lobbyists tend to have more negative than positive effects on US healthcare legislation, raising calls for reforms to promote transparency and limit undue influence (Reed & Ginsburg,
2018).
References
Reed, M., & Ginsburg, P. B. (2018). Reforming healthcare lobbying: Ensuring transparency and accountability.
Health Policy Journal, 45 (3), 245-257.
Shulman, K., & Ross, D. (2019). Influence of industry lobbying on drug pricing legislation. Journal of Health Economics, 67 , 110-125.
Johnson, L. M. (2020). Ethical considerations in healthcare lobbying.
American Journal of Bioethics, 20 (6), 34-42.
Bryan, T. T. (2017). Lobbying and healthcare policy development.
Policy Studies Journal, 45 (4), 567-585.
Kim, E., & Patel, R. (2021). The role of interest groups in shaping healthcare reform.
Public Health Reports, 136 (2), 212-220.
U.S. Congress. (2022). Lobbying disclosure act: An overview. Government Publishing Office . American Medical Association. (2020). Advocacy and policy influence. AMA Reports
.
Epstein, A. (2019). Pharmaceutical lobbying and drug prices: Ethical concerns. Bioethics Journal, 33 (7), 679-685.
Fletcher, S., & Murphy, J. (2018). Expanding scope of practice: Ethical and legal perspectives. Healthcare Law & Policy, 14 (1), 89-101.
Carroll, E. (2016). Influence of lobbying on healthcare policy: An analysis. Policy Analysis Quarterly, 3 (2), 45-60.